Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPB1 | P04792 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 11/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.57 |
| ▸ | LMNA | P02545 | 6/20 | 0.57 |
| ▸ | HTT | P42858 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | RGS12 | O14924 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.52 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.52 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10983574 | 0.87 | HSPB1 (0.55) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL1980920 | 0.87 | HSPB1 (0.55) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL17571121 | 0.85 | HSPB1 (0.59) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL11133456 | 0.84 | HSPB1 (0.58) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL1980276 | 0.83 | HSPB1 (0.56) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL4715000 | 0.82 | MAPT (0.57) | HSPB1MAPTSMN1; SMN2LMNAHTT | |
| SCHEMBL12469258 | 0.82 | MAPT (0.50) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL4715002 | 0.82 | MAPT (0.57) | HSPB1MAPTSMN1; SMN2LMNAHTT | |
| SCHEMBL16792542 | 0.82 | HSPB1 (0.75) | HSPB1MAPTPKMSMN1; SMN2LMNA | |
| SCHEMBL25184221 | 0.82 | KMT2A (0.60) | HSPB1MAPTPKMSMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4097111-B9 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2025-10-29 | — | — | EP | disclosed |
| US-12415815-B2 | Pyrido[2,3-e]oxazine derivatives as agricultural chemicals | GLOBACHEM NV (BE) | 2025-09-16 | — | — | US | disclosed |
| EP-4097111-B1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2025-07-23 | — | — | EP | disclosed |
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2023-05-18 | — | — | US | disclosed |
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | GLOBACHEM NV (BE) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151023-A1 | PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS | PNPO, HPD, PDXK | HSPB1 2806/4885MAPT 553/4885PKM 952/4885 |
| US-12415815-B2 | Pyrido[2,3-e]oxazine derivatives as agricultural chemicals | PNPO, HPD, PDXK | HSPB1 2806/4885MAPT 553/4885PKM 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.